Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein

Annals of the Rheumatic Diseases

Volumn 69, Issue 7, 2010, Pages 1383-1388

  Ryan, J G ^a   Masters, S L ^a   Booty, M G ^a   Habal, N ^a   Alexander, J D ^a   Barham, B K ^a   Remmers, E F ^a   Barron, K S ^b   Kastner, D L ^a   Aksentijevich, I ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; MYC PROTEIN; MYC PROTEIN P369S; MYC PROTEIN R408Q; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MARENOSTRIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DATA BASE; FAMILIAL AMYLOIDOSIS; FAMILIAL MEDITERRANEAN FEVER; FEVER; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; IMMUNOPRECIPITATION; LEG PAIN; MONARTHRITIS; PERICARDITIS; PERITONITIS; PHENOTYPE; PLEURISY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ADOLESCENT; ADULT; CHILD; DRUG ANTAGONISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; INFANT; MIDDLE AGED; MUTATION; ONSET AGE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; COLCHICINE; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77954999821     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.113415     Document Type: Article

References (33)

1. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997;90:797-807.
2. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997;17:25-31.
3. Touitou I, Lesage S, McDermott M, et al. Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum Mut 2004;24:194-8.
4. Yu JW, Fernandes-Alnemri T, Datta P, et al. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol Cell 2007;28:214-27.
5. Shoham NG, Centola M, Mansfield E, et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci USA 2003;100:13501-6.
6. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85.
7. Aksentijevich I, Torosyan Y, Samuels J, et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999;64:949-62.
8. Mitchell MK, Gregersen PK, Johnson S, et al. The New York Cancer Project: rationale, organization, design, and baseline characteristics. J Urban Health 2004;81:301-10.
9. Shi J, Blundell TL, Mizuguchi K. FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J Mol Biol 2001;310:243-57.
10. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997;18:2714-23.
11. Yalçinkaya F, Ozen S, Ozçakar ZB, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 2009;48:395-8.
12. Cazeneuve C, Sarkisian T, Pêcheux C, et al. MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 1999;65:88-97.
13. Touitou I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet 2001;9:473-83.
14. Sugiura T, Kawaguchi Y, Fujikawa S, et al. Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations. Mod Rheumatol 2008;18:57-9.
15. Daysal S, Akcil G, Goker B, et al. Infliximab therapy in a patient with familial Mediterranean fever and chronic hip arthritis. Arthritis Rheum 2005;53:146-7.
16. Seyahi E, Yazici H, Ozdogan H. Alternative treatments in colchicine-resistant patients with familial Mediterranean fever (FMF). FMF and beyond. In The Fourth International Congress on Systemic Autoinflammatory Diseases. November 2005, Bethesda, MD, 2005.
17. Fett DR, Putterman AM. Primary localized amyloidosis presenting as an eyelid margin tumor. Arch Ophthalmol 1986;104:584-5.
18. Pelton RW, Desmond BP, Mamalis N, et al. Nodular cutaneous amyloid tumors of the eyelids in the absence of systemic amyloidosis. Ophthalmic Surg Lasers 2001;32:422-4.
19. Mahajan D, Yadava U, Khurana N, et al. Primary localised nodular amyloidosis of the eyelid and conjunctiva: a case report. Pathology 2006;38:189-90.
20. Booth DR, Gillmore JD, Lachmann HJ, et al. The genetic basis of autosomal dominant familial Mediterranean fever. QJM 2000;93:217-21.
21. Database of Single Nucleotide Polymorphisms (dbSNP) National Center for Biotechnology Information. National Library of Medicine, Bethesda, MD. 15 July 2008. http://www.ncbi.nlm.nih.gov/SNP/ (accessed 10 August 2009).
22. Booth DR, Lachmann HJ, Gillmore JD, et al. Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148. QJM 2001;94:527-31.
23. Ben-Chetrit E, Lerer I, Malamud E, et al. The E148Q mutation in the MEFV gene: is it a disease-causing mutation or a sequence variant? Hum Mutat 2000;15:385-6.
24. Tchernitchko DO, Gérard-Blanluet M, Legendre M, et al. Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever. Ann Rheum Dis 2006;65:1154-7.
25. Tchernitchko D, Legendre M, Cazeneuve C, et al. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat 2003;22:339-40.
26. Konstantopoulos K, Kanta A, Lilakos K, et al. Familial Mediterranean fever and E148Q pyrin gene mutation in Greece. Int J Hematol 2005;81:26-8.
27. Topaloglu R, Ozaltin F, Yilmaz E, et al. E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever. Ann Rheum Dis 2005;64:750-2.
28. Schaner P, Richards N, Wadhwa A, et al. Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states. Nat Genet 2001;27:318-21.
29. Yamamoto K, Yamada R. Lessons from a genomewide association study of rheumatoid arthritis. N Engl J Med 2007;357:1250-1.
30. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008;40:695-701.
31. Singh-Grewal D, Chaitow J, Aksentijevich I, et al. Coexistent MEFV and CIAS1 mutations manifesting as familial Mediterranean fever plus deafness. Ann Rheum Dis 2007;66:1541.
32. Touitou I, Perez C, Dumont B, et al. Refractory auto-inflammatory syndrome associated with digenic transmission of low-penetrance tumour necrosis factor receptor-associated periodic syndrome and cryopyrin-associated periodic syndrome mutations. Ann Rheum Dis 2006;65:1530-1.
33. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005;17:586-99.